A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Weill Cornell Medical College /ID# 200109, New York

Hosp of the Univ of Penn /ID# 200348, Philadelphia

Johns Hopkins University /ID# 200349, Baltimore

David Geffen School of Medicin /ID# 200166, Los Angeles

UC San Francisco Medical Center-Parnassus /ID# 200205, San Francisco

Sylvester Comprehensive Cancer /ID# 200268, Miami

Northwestern Memorial Hospital /ID# 200230, Chicago

Norton Cancer Institute /ID# 200623, Louisville

Mayo Clinic - Rochester /ID# 200346, Rochester

Hackensack Univ Med Ctr /ID# 200229, Hackensack

MD Anderson Cancer Center at Texas Medical Center /ID# 206686, Houston